Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors.
10.3760/cma.j.issn.0529-5807.2013.01.009
- Author:
Song ZHENG
1
;
Jing JIA
;
Yue-long PAN
;
De-you TAO
;
Hong-sheng LU
Author Information
1. tztree@126.com
- Publication Type:Journal Article
- MeSH:
Aged;
Antineoplastic Agents;
therapeutic use;
Benzamides;
therapeutic use;
Drug Resistance, Neoplasm;
Exons;
Gastrectomy;
methods;
Gastrointestinal Neoplasms;
drug therapy;
metabolism;
pathology;
surgery;
Gastrointestinal Stromal Tumors;
drug therapy;
metabolism;
pathology;
surgery;
Humans;
Imatinib Mesylate;
Liver Neoplasms;
drug therapy;
secondary;
Male;
Piperazines;
therapeutic use;
Point Mutation;
Proto-Oncogene Proteins c-kit;
genetics;
metabolism;
Pyrimidines;
therapeutic use
- From:
Chinese Journal of Pathology
2013;42(1):42-43
- CountryChina
- Language:Chinese
